Genocea Biosciences, Inc. (GNCAQ)
Develops personalized cancer vaccines by analyzing each patient's tumor mutations.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+900.0%
The outlook
GNCAQ is trading at its 52-week high after climbing above both its 50- and 200-day moving averages, reflecting strong recent momentum. Analyst coverage appears minimal given the penny-stock price level. The current data shows the stock at an elevated position in its recent range, though investors should note the extremely low price and thin liquidity typical of this trading level.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$5,878
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—